5-hydroxydecanoate selectively reduces the initial increase in extracellular K+ in ischemic guinea-pig heart

Eur J Pharmacol. 1998 May 1;348(1):31-5. doi: 10.1016/s0014-2999(98)00238-6.

Abstract

The aim of the present study was to determine the effect of 5-hydroxydecanoate (5-HD) on extracellular K+ levels during global ischemia for 30 min employing K+-sensitive electrodes in isolated guinea-pig hearts. 5-HD (100 microM) reduced the K+ accumulation during the early period of ischemia, but did not inhibit the elevation of extracellular K+ in the latter half of the ischemic period which was selectively enhanced by ouabain (3 microM). Thus, 5-HD appears to exert a similar mode of action as glibenclamide on extracellular K+ accumulation in the ischemic guinea-pig hearts. The present study also strengthens the previous conclusion that an ATP-sensitive K+ channel contributes only to the initial increasing phase of extracellular K+ accumulation during ischemia in guinea-pig hearts.

MeSH terms

  • Animals
  • Cardiovascular Agents / pharmacology
  • Decanoic Acids / pharmacology*
  • Guinea Pigs
  • Heart / drug effects
  • Hydroxy Acids / pharmacology*
  • In Vitro Techniques
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Ischemia / physiopathology
  • Myocardium / metabolism*
  • Ouabain / pharmacology
  • Potassium / metabolism*
  • Potassium / pharmacology
  • Potassium Channel Blockers

Substances

  • Cardiovascular Agents
  • Decanoic Acids
  • Hydroxy Acids
  • Potassium Channel Blockers
  • Ouabain
  • 5-hydroxydecanoic acid
  • Potassium